Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
A multicentre retrospective analysis by the Italian Sarcoma Group evaluates the activity of chemotherapy in mesenchymal chondrosarcoma. This study provides insights into treatment efficacy for this rare sarcoma subtype.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.